Based on the MeRIP‐seq results and the previously identified abnormal abundance of ZFP14 in ccRCC, experiments were conducted to confirm whether ZFP14 is a downstream target of METTL14‐dominated m6A, potentially responsible for its impaired expression. This evidence concerns the gene ZFP14 and nonpapillary renal cell carcinoma.